SEC Company Response from VANTAGEMED CORP (CIK 0001099531) — Jul 7, 2005

VANTAGEMED CORP (CIK 0001099531)
Date: July 7, 2005 · CIK: 0001099531 · Accession: 0001047469-05-019003

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-123915

Date

July 6, 2005

Author

VANTAGEMED CORPORATION

Form

CORRESP

Company

VANTAGEMED CORP (CIK 0001099531)

Letter

Re: VantageMed Corporation (the "Company")

VANTAGEMED CORPORATION 11060 White Rock Road, Suite 210

Rancho Cordova, California 95670

July 5,

VIA FACSIMILE AND DIRECT TRANSMISSION

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Registration Statement on Form S-2

(File No. 333-123915)

Ladies and Gentleman:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Commission accelerate the effectiveness of the Registration Statement referenced above to 5:00 p.m., Eastern Time, on July 6, 2005, or as soon thereafter as practicable. The Company also hereby requests that a written order verifying the effective date be sent by mail.

The Company hereby acknowledges that:

•should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, the Commission is not foreclosed from taking any action with respect to the Registration Statement;

•the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

•the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. If you should have any questions, please call Kevin Coyle of DLA Piper Rudnick Gray Cary US LLP, counsel to the Company, at 916-930-3240.

Very truly yours,
VANTAGEMED CORPORATION

Show Raw Text

CORRESP
1
filename1.htm

VANTAGEMED CORPORATION
  11060 White Rock Road, Suite 210

Rancho Cordova, California 95670

July 5,
2005

VIA FACSIMILE AND DIRECT TRANSMISSION

Securities
and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Re: VantageMed Corporation (the "Company")

Registration Statement on Form S-2

(File No. 333-123915)

Ladies
and Gentleman:

        Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Commission accelerate the effectiveness of the Registration Statement
referenced above to 5:00 p.m., Eastern Time, on July 6, 2005, or as soon thereafter as practicable. The Company also hereby requests that a written order verifying the effective date be
sent by mail.

        The
Company hereby acknowledges that:

•should
the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, the Commission is not foreclosed from taking any
action with respect to the Registration Statement;

•the
action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its
full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

•the
Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

        Thank
you for your assistance. If you should have any questions, please call Kevin Coyle of DLA Piper Rudnick Gray Cary US LLP, counsel to the Company, at
916-930-3240.

Very truly yours,

VANTAGEMED CORPORATION

By:

/s/  PHILIP RANGER

Philip Ranger

Chief Financial Officer

cc:Mark
Shuman, Securities and Exchange Commission

Kevin Coyle

SecProbe.io